DM1 was associated with a lower probability of incident cardiovascular events than DM2, finds a new study analyzing over 162,000 patients from the Veradigm Metabolic Registry.
The FDA has approved tenecteplase for acute ischemic stroke, offering a faster and simpler administration compared to alteplase based on findings from the AcT trial.
Neither drug-coated balloons nor drug-eluting stents conferred significant clinical benefit over plain balloons and bare metal stents, finds the BASIL-3 trial, questioning the routine use of drug-coated devices in limb ischemia treatment.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Sisters of women with adverse pregnancy outcomes faced a "moderately increased risk of cardiovascular disease," according to findings from a Swedish cohort study.
Increased myocardial fibrosis predicts mortality post–AVR for both sexes, with researchers stating, Myocardial fibrosis provides significant prognostic information in men and women with AS.